Geneuro Net Income From Continuing Ops from 2010 to 2026

GNRO Stock  EUR 0.03  0.0002  0.65%   
Geneuro SA's Net Loss is decreasing over the years with slightly volatile fluctuation. Overall, Net Loss is projected to go to about -12.6 M this year. From 2010 to 2026 Geneuro SA Net Loss quarterly data regression line had arithmetic mean of (8,107,496) and r-squared of  0.64. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-13.3 M
Current Value
-12.6 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Geneuro SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Geneuro SA's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.3 K, Interest Expense of 1.2 M or Selling General Administrative of 3.6 M, as well as many indicators such as Price To Sales Ratio of 7.3 K, Dividend Yield of 0.0 or Days Sales Outstanding of 64.7 K. Geneuro financial statements analysis is a perfect complement when working with Geneuro SA Valuation or Volatility modules.
  
This module can also supplement various Geneuro SA Technical models . Check out the analysis of Geneuro SA Correlation against competitors.
Analyzing Geneuro SA's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing Geneuro SA's current valuation and future prospects.

Latest Geneuro SA's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Geneuro SA over the last few years. It is Geneuro SA's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Geneuro SA's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Geneuro Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(8,107,496)
Geometric Mean6,959,463
Coefficient Of Variation(61.16)
Mean Deviation4,176,361
Median(8,327,800)
Standard Deviation4,958,712
Sample Variance24.6T
Range16.5M
R-Value(0.80)
Mean Square Error9.3T
R-Squared0.64
Significance0.0001
Slope(787,998)
Total Sum of Squares393.4T

Geneuro Net Income From Continuing Ops History

2026-12.6 M
2025-13.3 M
2023-14.8 M
2022-12.2 M
2021-6.8 M
2020-9 M
2019-9.5 M

About Geneuro SA Financial Statements

Geneuro SA stakeholders use historical fundamental indicators, such as Geneuro SA's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Geneuro SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Geneuro SA's assets and liabilities are reflected in the revenues and expenses on Geneuro SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Geneuro SA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-13.3 M-12.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Geneuro Stock

Geneuro SA financial ratios help investors to determine whether Geneuro Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Geneuro with respect to the benefits of owning Geneuro SA security.